ARA-290
ATC code L04
AZD-1480
Abatacept
Abetimus
Abrocitinib
Adalimumab
Adcirca
Afelimomab
Aflibercept
Agerafenib
Albinterferon
Alefacept
Alemtuzumab
Alfred G. Gilman
Alopecia areata
American Society of Health-System Pharmacists
Amyvid
Anakinra
Anatomical Therapeutic Chemical Classification System
Anifrolumab
Anti-lymphocyte globulin
Anti-thymocyte globulin
Antibody
Antifolate
Antimetabolite
Apremilast
Aselizumab
Asialo erythropoietin
Atiprimod
Atomoxetine
Atorolimumab
Avacopan
Azathioprine
Bamlanivimab
Baqsimi
Baricitinib (data page)
Basaglar
Basigin
Basiliximab
Begelomab
Belatacept
Belimumab
Bertilimumab
Bibcode (identifier)
Bifarcept
Bimekizumab
Bioavailability
Biological half-life
Blisibimod
Blood plasma
Board of directors
Boxed warning
Breakthrough therapy
Briakinumab
Brodalumab
CAS Registry Number
CD117
CD11a
CD154
CD18
CD20
CD23
CD3 (immunology)
CD4
CD40 (protein)
CD80
CHZ868
CNTO-530
COVID-19
CTLA-4
CYP2C19
CYP2C9
CYP3A4
CYT387
Calcineurin
Canakinumab
Carbamylated erythropoietin
Cardiotrophin 1
Cedelizumab
Cercosporamide
Certolizumab pegol
ChEBI
ChEMBL
ChemSpider
Chemical formula
Chemokine receptor
Chloramphenicol acetyltransferase
Cholesterol
Ciclosporin
Cilmostim
Clenoliximab
Colony-stimulating factor receptor
Committee for Medicinal Products for Human Use
CompTox Chemicals Dashboard
Complement component 5
Corporation
Crovalimab
Cucurbitacin I
Cyclophilin
Cyramza
Cytokine receptor
Cytokine storm
Daclizumab
DailyMed
Danicopan
Darbepoetin alfa
Darvadstrocel
Decernotinib
Deucravacitinib
Deuruxolitinib
Dihydroorotate dehydrogenase
Dimethyl fumarate
Diroximel fumarate
Doi (identifier)
Douglas R. Oberhelman
Drotrecogin alfa
DrugBank
Drug metabolism
Drug nomenclature
Drugs.com
Duloxetine
ECHA InfoCard
Ecogramostim
Eculizumab
Efalizumab
Efgartigimod alfa
Efgartigimod alfa/hyaluronidase
Eli Lilly and Company
Elimination half-life
Ellen R. Marram
Elsilimomab
Eltrombopag
Emapalumab
Emergency use authorization
Emfilermin
Emgality
Enzyme inducer
Epoetin alfa
Epoetin beta
Epoetin delta
Epoetin epsilon
Epoetin gamma
Epoetin kappa
Epoetin omega
Epoetin theta
Epoetin zeta
Erbitux
Erlizumab
Erythropoietin
Erythropoietin-Fc
Erythropoietin receptor
Etanercept
Etesevimab
Etrasimod
European Medicines Agency
Everolimus
Excretion
Extracorporeal membrane oxygenation
FDA
FKBP
FMS-like tyrosine kinase 3 ligand
Faeces
Faralimomab
Fedratinib
Filgotinib
Filgrastim
Fingolimod
Fluoxetine
Fontolizumab
Food and Drug Administration
Franklyn G. Prendergast
Frexalimab
Fusion protein
Galiximab
Gastroenteritis
Gavilimomab
Gemcitabine
Gene expression
Glucagon (medication)
Glyxambi
Golimumab
Gomiliximab
Granulocyte colony-stimulating factor
Granulocyte colony-stimulating factor receptor
Granulocyte macrophage colony-stimulating factor
Granulocyte macrophage colony-stimulating factor receptor
Guselkumab
Gusperimus
Half maximal inhibitory concentration
Hdl (identifier)
Health Canada
Herpes simplex
Herpes zoster
Humatrope
Humulin
Hypercholesterolemia
IFNA10
IFNA13
IFNA14
IFNA16
IFNA17
IFNA2
IFNA21
IFNA4
IFNA5
IFNA6
IFNA7
IFNA8
IFNB1
IFNB3
IL-2 receptor
IUPAC nomenclature of chemistry
Immunoglobulin E
Immunomodulatory
Immunomodulatory imide drug
Immunosuppressant
Immunosuppression
Immunosuppressive drug
In vitro
Incyte
Inebilizumab
Infliximab
Inolimomab
Insulin lispro
Integrin
Interferon
Interferon-alpha/beta receptor
Interferon-gamma receptor
Interferon-lambda receptor
Interferon alfa
Interferon alfa 2a
Interferon alfa 2b
Interferon alfa n1
Interferon alfacon-1
Interferon alpha
Interferon alpha-n3
Interferon alpha 1
Interferon beta
Interferon beta 1a
Interferon beta 1b
Interferon gamma
Interferon gamma 1b
Interferon kappa
Interferon omega
Interferon receptor
Interleukin
Interleukin-34
Interleukin-6 receptor
Interleukin 12
Interleukin 13
Interleukin 17
Interleukin 1 receptor antagonist
Interleukin 2
Interleukin 23
Interleukin 5
Interleukin 6
Interleukin receptor
International Chemical Identifier
Iptacopan
Itacitinib
Ixekizumab
J. Erik Fyrwald
JAK1
JAK2
JAK3
JSmol
Janus kinase
Janus kinase 1
Janus kinase 2
Janus kinase 3
Janus kinase inhibitor
Jardiance
Jaypirca
Jentadueto
John C. Lechleiter
KEGG
Karen N. Horn
Kathi Seifert
Keliximab
Kisunla
L-selectin
Lanimostim
Lebrikizumab
Leflunomide
Lenalidomide
Lenograstim
Lerdelimumab
Leridistim
Lestaurtinib
Leukemia inhibitory factor
Lipegfilgrastim
Lumiliximab
Lymphocyte function-associated antigen 1
Lyumjev
MEDI-545
MTOR
Macrolide
Macrophage colony-stimulating factor
Macrophage colony-stimulating factor receptor
Martin Feldstein
Maslimomab
Mavrilimumab
Medication
MedlinePlus
Mepolizumab
Metabolized
Metelimumab
Methotrexate
Methoxy polyethylene glycol-epoetin beta
Michael L. Eskew
Midostaurin
Milodistim
Mirimostim
Molar mass
Molgramostim
Momelotinib
Monoclonal antibody
Morolimumab
Muromonab-CD3
Mycophenolic acid
NSC-33994
NSC-7908
Namilumab
Nanomolar
Nartograstim
Natalizumab
National Institute of Allergy and Infectious Diseases
Nerelimomab
Netakimab
New drug application
Obinutuzumab
Oclacitinib
Ocrelizumab
Ocrelizumab/hyaluronidase
Odulimomab
Ofatumumab
Olanzapine
Olanzapine/fluoxetine
Olokizumab
Olumiant
Omalizumab
Oncostatin M
Opinercept
Oral administration
Otelixizumab
Otilimab
Ozanimod
PDE4 inhibitor
PMC (identifier)
PMID (identifier)
Pacritinib
Pascolizumab
Peficitinib
Pegacaristim
Pegcetacoplan
Pegfilgrastim
Peginesatide
Peginterferon alfa-2a
Peginterferon alfa-2b
Pegnartograstim
Pegol sihematide
Pemetrexed
Pexelizumab
Pharmacokinetics
Pimecrolimus
Pirfenidone
Plasma protein
Plasma protein binding
Polyclonal antibodies
Pomalidomide
Ponesimod
Portrazza
Pregnancy category
Prescription drug
Promegapoietin
Protein Data Bank
PubChem
Public domain
Purine synthesis inhibitor
Quizartinib
RECOVERY Trial
Raloxifene
Ralph Alvarez
Ravulizumab
Receptor modulator
Regramostim
Regulation of therapeutic goods
Remdesivir
Reslizumab
Retevmo
Reyvow
Rheumatoid arthritis
Ridaforolimus
Rifampicin
Rilonacept
Risankizumab
Ritlecitinib
Rituximab
Romiplostim
Rontalizumab
Route of administration
Rovelizumab
Rozanolixizumab
Ruplizumab
Ruxolitinib
S2CID (identifier)
SD-1008
SLC22A1
STAT protein
Sargramostim
Sarilumab
Satralizumab
Secukinumab
Sifalimumab
Signal transduction
Siltuximab
Simplified molecular-input line-entry system
Siplizumab
Siponimod
Sirolimus
Sirukumab
Solidarity trial
Sorafenib
Spesolimab
Standard for the Uniform Scheduling of Medicines and Poisons
Sunitinib
Sutimlimab
Synjardy
TCS-21311
TNF inhibitor
T cell
Tacrolimus
Tadalafil
Talizumab
Taltz
Telimomab aritox
Telitacicept
Temsirolimus
Teneliximab
Teplizumab
Teprotumumab
Teriflunomide
Teriparatide
Thalidomide
Therapeutic Goods Administration
Thrombopoietin
Thrombopoietin receptor
Thymic stromal lymphopoietin
Tildrakizumab
Tocilizumab
Tofacitinib
Toralizumab
Tradjenta
Transforming growth factor beta receptor
Transporter protein
Trijardy
Trulicity
Tumor necrosis factor receptor
Tyrosine kinase 2
Ublituximab
Umirolimus
Unique Ingredient Identifier
Upadacitinib
Upper respiratory tract infection
Urinary tract infection
Ustekinumab
Vapaliximab
Vedolizumab
Vepalimomab
Verzenio
Visilizumab
Voclosporin
WHI-P 154
Winfried Bischoff
World Health Organization
ZM-39923
ZM-449829
Zanolimumab
Zolimomab aritox
Zotarolimus